Loading...
Market
Sanofi investment reduces French vaccine dependency by 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
EU health reports, Sanofi press releases
Story
Sanofi Invests $1.08 Billion in French Biomanufacturing, Boosts EU Health Sovereignty
May 13, 2024, 06:45 AM
Sanofi announced plans to invest over 1 billion euros ($1.08 billion) to enhance its drug and vaccine production capabilities across three of its sites in France. This investment aims to expand biomanufacturing capacities and is part of a broader initiative to promote health sovereignty within the European Union.
View original story
Similar markets
Yes • 50%
No • 50%
Reduction by more than 20% • 33%
Reduction by 10% to 20% • 33%
Less than 10% reduction • 33%
COVID-19 vaccines • 33%
Influenza vaccines • 33%
Other vaccines • 34%